Kenji Yamamoto a medical doctor at Okamura Memorial Hospital (Japan), Division of Cardiovascular Surgery wrote an article that was published on the BMC. Dr. Yamamoto’s article was titled Adverse effects of COVID-19 vaccines and measures to prevent them. You can read it in full here.

 

According to medifind; Kenji Yamamoto practices in Shizuoka, Japan. Yamamoto is highly rated in 2 conditions, according to our data. His top areas of expertise are N-Acetyl-Alpha-D-Galactosaminidase Deficiency Type 3, Varicose Veins, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

 

The doctor’s findings were recieved by the BMC the 20th of March, 2022. They accepted his article, the 1st of June, 2022 and then finally published it four days later on the 5th of June of 2022.

 

 

Yamamoto’s abstract findings

 

Some studies suggest a link between COVID-19 vaccines and reactivation of the virus that causes shingles (here). This condition is sometimes referred to as vaccine-acquired immunodeficiency syndrome.

 

Since December 2021, besides COVID-19, Department of Cardiovascular Surgery, Okamura Memorial Hospital, Shizuoka, Japan (where Yamamoto works) (hereinafter referred to as “the institute”) has encountered cases of infections that are difficult to control.

 

For example, there were several cases of suspected infections due to inflammation after open-heart surgery, which could not be controlled even after several weeks of use of multiple antibiotics. The patients showed signs of being immunocompromised, and there were a few deaths. The risk of infection may increase. Dr Yamamoto goes on to say that various medical algorithms for evaluating postoperative prognosis may have to be revised in the future.

 

Dr. Yamamoto’s alarming findings

 

The media have so far concealed the adverse events of vaccine administration, such as vaccine-induced immune thrombotic thrombocytopenia (VITT), owing to biased propaganda. The institute encounters many cases in which this cause is recognized. These situations have occurred in waves; however, they are yet to be resolved despite the measures implemented to routinely screen patients admitted for surgery for heparin-induced thrombocytopenia (HIT) antibodies. Four HIT antibody-positive cases have been confirmed at the institute since the start of vaccination; this frequency of HIT antibody-positive cases has rarely been observed before. Fatal cases due to VITT following the administration of COVID-19 vaccines have also been reported [15].

 

The media have so far concealed the adverse events of vaccine administration, such as vaccine-induced immune thrombotic thrombocytopenia (VITT), owing to biased propaganda. – Dr. Kenji Yamamoto

What is causing a decrease in immunity?

 

Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated individuals. According to European Medicines Agency recommendations, frequent COVID-19 booster shots could adversely affect the immune response and may not be feasible.

 

Dr Yamamoto explains that the decrease in immunity can be caused by several factors such as N1-methylpseudouridine, the spike protein, lipid nanoparticles, antibody-dependent enhancement, and the original antigenic stimulus. These clinical alterations may explain the association reported between COVID-19 vaccination and shingles. You can read that study here.

 

Dr Yamamoto further explains,  the spike proteins do not immediately decay following the administration of mRNA vaccines. The spike proteins present on exosomes circulate throughout the body for more than 4 months. You can read more on that here.

 

In addition to Dr. Yamamoto’s findings, in vivo studies have shown that lipid nanoparticles (LNPs) accumulate in the liver, spleen, adrenal glands, and ovaries, and that LNP-encapsulated mRNA is highly inflammatory. More here.

 

Newly generated antibodies of the spike protein damage the cells and tissues that are primed to produce spike proteins (here), and vascular endothelial cells are damaged by spike proteins in the bloodstream (here); this may damage the immune system organs such as the adrenal gland. Additionally, antibody-dependent enhancement may occur, wherein infection-enhancing antibodies attenuate the effect of neutralizing antibodies in preventing infection (here.)

 

The original antigenic sin (here), that is, the residual immune memory of the Wuhan-type vaccine may prevent the vaccine from being sufficiently effective against variant strains. These mechanisms may also be involved in the exacerbation of COVID-19.

 

 

Dr. Yamamoto reccomends

 

  • As a safety measure, further booster vaccinations should be discontinued.

 

  • In addition, the date of vaccination and the time since the last vaccination should be recorded in the medical record of patients. Owing to the lack of awareness of this disease group among physicians and general public in Japan, a history of COVID-19 vaccination is often not documented, as it is in the case of influenza vaccination.

 

  • The time elapsed since the last COVID-19 vaccination may need to be considered when invasive procedures are required.

“As a safety measure, further booster vaccinations should be discontinued.” – Dr. Yamamoto

 

Dr. Yamamoto’s pratical measures to prevent decrease in immunity

 

Several practical measures that can be implemented to prevent a decrease in immunity have been reported. These include limiting the use of non-steroidal anti-inflammatory drugs, including acetaminophen, to maintain deep body temperature, appropriate use of antibiotics, smoking cessation, stress control, and limiting the use of lipid emulsions, including propofol, which may cause perioperative immunosuppression.

 

Dr. Yamamoto’s conclusion

 

“In conclusion, COVID-19 vaccination is a major risk factor for infections in critically ill patients.” – Dr. Yamamoto

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

References

  1. Nordström P, Ballin M, Nordström A. Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden. Lancet. 2022;399:814–23. https://doi.org/10.1016/S0140-6736(22)00089-7.

    Article PubMed PubMed Central Google Scholar

  2. European Centre for Disease Prevention and Control. Interim public health considerations for the provision of additional COVID-19 vaccine doses. https://www.ecdc.europa.eu/en/publications-data/covid-19-public-health-considerations-additional-vaccine-doses. Accessed 4 May 2022.

  3. Mallapaty S. Fourth dose of COVID vaccine offers only slight boost against Omicron infection. Nature. 2022. https://doi.org/10.1038/D41586-022-00486-9.

    Article PubMed Google Scholar

  4. Krienke C, Kolb L, Diken E, Streuber M, Kirchhoff S, Bukur T, et al. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science. 2021;371:145–53. https://doi.org/10.1126/science.aay3638.

    Article CAS PubMed Google Scholar

  5. Bansal S, Perincheri S, Fleming T, Poulson C, Tiffany B, Bremner RM, et al. Cutting edge: circulating exosomes with COVID spike protein are induced by BNT162b2 (Pfizer–BioNTech) vaccination prior to development of antibodies: a novel mechanism for immune activation by mRNA vaccines. J Immunol. 2021;207:2405–10. https://doi.org/10.4049/jimmunol.2100637.

    Article CAS PubMed Google Scholar

  6. BNT162b2 Module 2.4. Nonclinical Overview. FDA-CBER-2021-4379-0000681 JW-v-HHS-prod-3-02418.pdf (judicialwatch.org) Access 6 May 2022.

  7. Ndeupen S, Qin Z, Jacobsen S, Bouteau A, Estanbouli H, Igyártó BZ. The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. Science. 2021;24:103479. https://doi.org/10.1016/j.isci.2021.103479.

    Article CAS Google Scholar

  8. Yamamoto K. Risk of heparinoid use in cosmetics and moisturizers in individuals vaccinated against severe acute respiratory syndrome coronavirus. Thromb J. 2021. https://doi.org/10.1186/s12959-021-00320-8.

    Article PubMed PubMed Central Google Scholar

  9. Lei Y, Zhang J, Schiavon CR, He M, Chen L, Shen H, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res. 2021;128:1323–6. https://doi.org/10.1161/CIRCRESAHA.121.318902.

    Article CAS PubMed PubMed Central Google Scholar

  10. Liu Y, Soh WT, Kishikawa JI, Hirose M, Nakayama EE, Li S, et al. An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies. Cell. 2021;184:3452-66.e18. https://doi.org/10.1016/j.cell.2021.05.032.

    Article CAS PubMed PubMed Central Google Scholar

  11. Cho A, Muecksch F, Schaefer-Babajew D, Wang Z, Finkin S, Gaebler C, et al. Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination. Nature. 2021;600:517–22. https://doi.org/10.1038/s41586-021-04060-7.

    Article CAS PubMed PubMed Central Google Scholar

  12. Desai HD, Sharma K, Shah A, Patoliya J, Patil A, Hooshanginezhad Z, et al. Can SARS-CoV-2 vaccine increase the risk of reactivation of Varicella zoster. Systematic review. J Cosmet Dermatol. 2021;20:3350–61. https://doi.org/10.1111/jocd.14521.

    Article PubMed PubMed Central Google Scholar

  13. Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, et al. Safety of the BNT162b2 mRNA Covid-19 v in a nationwide setting. N Engl J Med. 2021;385:1078–90. https://doi.org/10.1056/NEJMOA2110475.

    Article CAS PubMed Google Scholar

  14. Seneff S, Nigh G, Kyriakopoulos AM, McCullough PA. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: the role of G-quadruplexes, exosomes, and MicroRNAs. Food Chem Toxicol. 2022;164:113008. https://doi.org/10.1016/J.FCT.2022.113008.

    Article CAS PubMed PubMed Central Google Scholar

  15. Lee EJ, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD, et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 2021;96:534–7. https://doi.org/10.1002/AJH.26132.

    Article CAS PubMed PubMed Central Google Scholar

  16. Yamamoto K. Five important preventive measures against the exacerbation of coronavirus disease. Anaesthesiol Intensive Ther. 2021;53:358–9. https://doi.org/10.5114/ait.2021.108581.

    Article PubMed Google Scholar

  17. Yamamoto K. Risk of propofol use for sedation in COVID-19 patient. Anaesthesiol Intensive Ther. 2020;52:354–5. https://doi.org/10.5114/ait.2020.100477.

    Article PubMed Google Scholar

  18. Gundry SR. Observational findings of PULS cardiac test findings for inflammatory markers in patients receiving mRNA vaccines. Circulation. 2021;144(suppl_1):A10712–A10712. https://doi.org/10.1161/circ.144.suppl_1.10712.

    Article Google Scholar

  19. Lai FTT, Li X, Peng K, Huang L, Ip P, Tong X, et al. Carditis After COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine: a case-control study. Ann Intern Med. 2022;175:362–70. https://doi.org/10.7326/M21-3700.

    Article PubMed Google Scholar

Meet Lauren

With over 15 years of herbal knowledge, Lauren not only has hands on experience,
she has spent the last 10 years devoted to expanding her herbal knowledge…

Learn More >>

Recent Posts

The Author

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart